Last Price
0.72
Today's Change
0.00 (0.00%)
Day's Change
0.70 - 0.75
Trading Volume
95,600
Profile
MSCL
Exchange: Toronto Stock Exchange Ventures Toronto Stock Exchange Ventures
Currency: CAD CAD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Francis Gleeson B.B.A. M.B.A Mr. Francis Gleeson B.B.A. M.B.A
Full Time Employees: 0 0
IPO Date: 2008-01-07 2008-01-07
ISIN: CA80401L3083 CA80401L3083
Beta: 1.21 1.21
Last Dividend: 0.00 0.00
Dcf Diff: 0.51 0.51
Dcf: 0.05 0.05
Description
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
War World 3?
Poll Closed Upcoming PollIs WW3 coming?
Select only one answer
Yes, we are very close to it!
1 vote(s)
50.00%
No, we are not there yet!
0 vote(s)
0%
Possible a regional war - not full scale WW3
1 vote(s)
50.00%
1713671999000
Top Articles
1
CEO Morning Brief
Canada Hikes Capital Gains Tax to Raise Billions for Housing
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
